Home mouth swab drug tests use oral fluid, commonly called saliva, as the specimen. Home testing can mean either a rapid test performed at home or a collection kit whose sample is sent to a laboratory. The location where a sample is collected does not, by itself, identify where the analysis takes place.
MedlinePlus, a service of the National Library of Medicine, describes these two home testing formats separately. A rapid home test produces a screening result at home. A self collection kit gathers saliva or another specimen for analysis elsewhere. FDA’s collection kit explanation likewise includes saliva among the materials that can be collected and shipped to a laboratory. The laboratory performs preliminary analysis and additional testing when the screen suggests possible drug presence.
The specimen type does not identify the complete drug panel. NIDA explains that drug tests target particular drugs or drug classes above a specified cutoff. A saliva test therefore answers a question about the targets included in that test, rather than providing a complete substance inventory. The kit’s stated specimen and analytical targets are different details from whether it provides a rapid screen or laboratory analysis.
Screening and confirmation are also different stages. MedlinePlus explains that a positive home test needs laboratory follow up to check the result’s accuracy. FDA notes that a negative collection kit result may occur when the specimen does not contain detectable drugs at the time of collection. Neither result supplies a diagnosis of a substance use disorder, which NIDA distinguishes from drug testing.
This consumer explanation is separate from DOT oral fluid testing. Section 40.210 describes DOT drug testing using specimens screened and confirmed at HHS certified laboratories and excludes instant and point of collection oral fluid tests. This FAQ does not address the availability of DOT oral fluid testing, collector qualifications, or how to conduct a regulated collection.
Sources
Ready to get started?